Invest directly in ASX IPOs with OnMarket

No more long application forms. Bid online in 5 easy steps.

Tap 'More Info' to get access to free research, all company releases, and bid instantly for shares.

Wholesale Live

Baymatob Pty Ltd

AI platform for $5.7B fetal monitoring market, FDA Breakthrough Designation


Baymatob is a medtech company revolutionising maternal care with Oli™, an AI-driven tool for early detection of pregnancy and labor complications. Backed by Perennial, and Scale Investors, Oli targets the $5.7B fetal monitoring market and has FDA Breakthrough Designation (expedited review) to improve outcomes and reduce costly interventions.

$1.91Price
Up to $12 millionSize of Offer
22 Jul 25Offer Open
05 Aug 25Pay By

Join for free, view offers videos & independent research, then set up an Investment profile

Bid into the offer in 5 easy steps, secure payment via BPay

 

Allocated shares will seamlessly appear in your online broking account